Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty

Recruiting

Phase 2

CannabidiolCannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty

Sponsor:

Chad Brummett

Code:

NCT06234631

Conditions

Knee Replacement Surgery

Osteoarthritis, Knee

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Epidiolex oral solution

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-17. This information was provided to ClinicalTrials.gov by Chad Brummett on 2025-03-19.